ABBOTT LABORATORIES Debt Instrument, Face Amount
ABBOTT LABORATORIES (ABT) had Debt Instrument, Face Amount of $15.10 billion as of 2016-11-30, per its 10-K filed 2019-02-22.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2019-02-22
- 2016-11-30: Debt Instrument, Face Amount $15.10B.
- 2015-03-31: Debt Instrument, Face Amount $2.50B.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2016-11-30 | $15.10B 10-K · filed 2019-02-22 |
| 2015-03-31 | $2.50B 10-K · filed 2018-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |